Hege Sollie-Zetlmayer
Board Member
Ptc Therapeutics, Inc. (PTCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hege Sollie-Zetlmayer
Hege Sollie-Zetlmayer is recorded as Board Member at Ptc Therapeutics, Inc. (PTCT). Ptc Therapeutics, Inc. reported in an 8-K filed July 30, 2026 that Hege Sollie-Zetlmayer was appointed director, effective July 28, 2026.
“On July 28, 2026, the Company appointed Hege Sollie-Zetlmayer to its board of directors (the "Board"), effective immediately, filling a vacancy on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-07-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ptc Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Matthew B. Klein CEO, Board Member
- Matthew B. Klein CEO
- Matthew Klein CEO, Board Member
- Michael Schmertzler CFO
- Mark E. Boulding General Counsel
- Christine Utter Chief Accounting Officer
- Allan Jacobson Board Member
- David P. Southwell Board Member
- Jessica Chutter Board Member
- William F. Bell Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.